Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002961209 | SCV003677025 | uncertain significance | Inborn genetic diseases | 2022-03-15 | criteria provided, single submitter | clinical testing | The c.445_447delGTT (p.V149del) alteration is located in exon 2 (coding exon 1) of the ZBTB24 gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.445 and c.447, resulting in the deletion of 1 residue. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003111727 | SCV003789221 | uncertain significance | Immunodeficiency-centromeric instability-facial anomalies syndrome 2 | 2022-04-15 | criteria provided, single submitter | clinical testing | This variant, c.445_447del, results in the deletion of 1 amino acid(s) of the ZBTB24 protein (p.Val149del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs749390499, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with ZBTB24-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |